BE645047A - - Google Patents
Info
- Publication number
- BE645047A BE645047A BE645047DA BE645047A BE 645047 A BE645047 A BE 645047A BE 645047D A BE645047D A BE 645047DA BE 645047 A BE645047 A BE 645047A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32651—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9762/63A GB1015251A (en) | 1963-03-12 | 1963-03-12 | Aqueous pharmaceutical compositions in capsule form |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE645047A true BE645047A (US08118993-20120221-C00002.png) | 1964-07-01 |
Family
ID=9878297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE645047D BE645047A (US08118993-20120221-C00002.png) | 1963-03-12 | 1964-03-11 |
Country Status (5)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0544612A2 (en) * | 1991-11-25 | 1993-06-02 | The Nisshin Oil Mills, Ltd. | Composition comprising an immunogen and a triglyceride |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1792410B2 (de) * | 1967-09-01 | 1980-03-13 | Apoteksvarucentralen Vitrum Apotekareaktiebolaget, Stockholm | Arzneimittelzubereitung zur intravenösen Injektion |
| US3851051A (en) * | 1970-07-17 | 1974-11-26 | Scherer R Corp | Soft gelatin capsule containing high water content fill |
| GB1502774A (en) * | 1974-06-25 | 1978-03-01 | Nat Res Dev | Immunological preparations |
| NL8301996A (nl) * | 1983-06-06 | 1985-01-02 | Duphar Int Res | Werkwijze ter bereiding van geadjuveerde levende vaccins en aldus verkregen geadjuveerde levende vaccins. |
| US5112619A (en) * | 1985-11-12 | 1992-05-12 | Eli Lilly And Company | Orally administerable sustained release pharmaceutical formulation |
| JP3313124B2 (ja) * | 1991-07-31 | 2002-08-12 | 森下仁丹株式会社 | 親水性物質を内容物とするシームレスカプセルおよびその製法 |
| US5538737A (en) * | 1994-11-30 | 1996-07-23 | Applied Analytical Industries, Inc. | Oral compositions of H2 -antagonists |
| KR100462690B1 (ko) * | 1996-01-30 | 2005-04-20 | 신젠타 리미티드 | 포장된농약조성물 |
| NO20021592D0 (no) * | 2002-04-04 | 2002-04-04 | Fmc Biopolymer As | Polysakkaridkapsler og fremgangsmåte ved fremstilling derav |
| ES2592504T3 (es) * | 2003-07-17 | 2016-11-30 | Banner Life Sciences, LLC | Preparaciones de liberación controlada |
| US8075910B2 (en) * | 2004-05-20 | 2011-12-13 | Pbm Pharmaceuticals, Inc. | Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions |
| US20070172965A1 (en) * | 2006-01-23 | 2007-07-26 | Kangguo Cheng | Non-destructive trench volume determination and trench capacitance projection |
| EP1991196B1 (en) * | 2006-03-03 | 2016-10-12 | Fmc Corporation | Method and apparatus for the preparation of capsules. |
| WO2008049552A1 (en) * | 2006-10-24 | 2008-05-02 | Helsinn Healthcare S.A. | Soft capsules comprising palonosetron hydrochloride having improved stability and bioavailability |
| US20100062057A1 (en) * | 2008-09-10 | 2010-03-11 | Pronova BioPharma Norge AS. | Formulation |
| KR101900505B1 (ko) * | 2009-09-10 | 2018-09-19 | 에프엠씨 코포레이션 | 고강도의 이음매 없는 알기네이트 캡슐 |
| MX2020008813A (es) * | 2018-02-26 | 2020-09-28 | Scherer Technologies Llc R P | Forma de dosificacion farmaceutica para una emulsion de simeticona y loperamida. |
| GB202109464D0 (en) | 2021-06-30 | 2021-08-11 | Norwegian Univ Sci & Tech Ntnu | Soft gel capsule |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3126321A (en) * | 1964-03-24 | Table vii | ||
| US2183053A (en) * | 1936-12-03 | 1939-12-12 | Atlantic Coast Fisheries Co | Vitamin preparation and method of making same |
| US2314527A (en) * | 1940-07-06 | 1943-03-23 | Atlantic Coast Fisheries Co | Method of making sealed capsules |
| US2780355A (en) * | 1953-11-09 | 1957-02-05 | Scherer Corp R P | Gelatin capsule containing water soluble substances |
| US2946724A (en) * | 1957-05-29 | 1960-07-26 | American Cyanamid Co | Stable poliomyelitis live virus vaccine |
| US2966443A (en) * | 1959-06-22 | 1960-12-27 | American Cyanamid Co | Trivalent poliomyelitis live virus vaccine |
| US3099601A (en) * | 1959-10-02 | 1963-07-30 | Anchor Serum Company | Bacterin in aqueous polyethylene, mineral oil emulsion |
| US3096249A (en) * | 1960-05-10 | 1963-07-02 | Samuel J Prigal | Emulsion composition |
| GB914894A (en) * | 1960-08-12 | 1963-01-09 | Beecham Res Lab | Injectable pharmaceutical media |
| US3149036A (en) * | 1961-10-16 | 1964-09-15 | Merck & Co Inc | Adjuvant vaccine with aluminum monostearate, mannide monooleate, vegetable oil, and an aqueous phase immunolgical agent |
| US3185625A (en) * | 1961-11-08 | 1965-05-25 | Brown Ethan Allan | Injectionable substances |
-
1963
- 1963-03-12 GB GB9762/63A patent/GB1015251A/en not_active Expired
-
1964
- 1964-03-06 US US350087A patent/US3376199A/en not_active Expired - Lifetime
- 1964-03-11 BE BE645047D patent/BE645047A/xx unknown
- 1964-03-12 DE DE1467907A patent/DE1467907C3/de not_active Expired
- 1964-06-03 FR FR976927A patent/FR3922M/fr not_active Expired
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0544612A2 (en) * | 1991-11-25 | 1993-06-02 | The Nisshin Oil Mills, Ltd. | Composition comprising an immunogen and a triglyceride |
| EP0544612A3 (en) * | 1991-11-25 | 1994-08-10 | Nisshin Oil Mills Ltd | Composition comprising an immunogen and a triglyceride |
Also Published As
| Publication number | Publication date |
|---|---|
| DE1467907C3 (de) | 1973-09-27 |
| FR3922M (US08118993-20120221-C00002.png) | 1966-02-14 |
| DE1467907B2 (de) | 1973-03-08 |
| GB1015251A (en) | 1965-12-31 |
| US3376199A (en) | 1968-04-02 |
| DE1467907A1 (de) | 1969-01-23 |
